Sabra Q2 Normalized FFO $0.37; invests $122M YTD; closes $500M term loan; updates FY guidance

Sabra Health Care REIT, Inc.

2025-Q2 EPS reported $0.44 revenue$372,693,000

Q2 Normalized FFO $0.37, Normalized AFFO $0.38, Net Income $0.27 per diluted share.
Closed $500M unsecured term loan at fixed 4.64% due 2030; redeemed $500M 5.125% notes due 2026.
Invested $122.3M YTD in senior housing at 7.5-7.7% cash yields; awarded $220M additional investments.
Same store managed senior housing Cash NOI up 17.1% YoY; EBITDARM coverage improved across all segments.
Updated FY2025 guidance: Normalized FFO $1.45-$1.47, Normalized AFFO $1.49-$1.51; dividend $0.30/share.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.